Cancer Vaccine

News, features, and commentary about cancer-related issues

A cluster of cancers caused by HPV are now preventable, but the vaccine is under constant siege from politicians.

In a significant breakthrough, the world's first mRNA lung cancer vaccine trials have been launched across seven countries, marking a new era in cancer treatment.  This innovative vaccine, known as BNT116 and developed by BioNTech, is designed to combat non-small cell lung cancer (NSCLC)—the most common form of the disease.  By instructing the immune system […]

It has not been shown that COVID-19 vaccines cause or accelerate cancer. Yet opponents of the vaccines say a new review article "has found that COVID-19 mRNA vaccines could aid cancer development." The review conclusions are mainly based on the misinterpretation of a study on mRNA cancer vaccines in mice.

After years of lackluster results, cancer vaccines seem poised for success. Finally.

Olivia Munn credits the Breast Cancer Risk Assessment Tool with saving her life. It's free to use online.

News, features, and commentary about cancer-related issues

The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot.

Trials show new cancer vaccine could improve patient survival for some lung cancers by nearly half  EuronewsCancer vaccine: Tedopi shows positive results for a lung cancer | Latest News | WION  WIONHopes over French firm's vaccine to treat lung cancer  The ConnexionTedopi: positive results for a lung cancer vaccine  africanewsNovel vaccine delivers significant survival in lung cancer trial  European Pharmaceutical…

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues

By silencing the molecular pathway that prevents macrophages from attacking our own cells, Penn Engineers have manipulated these white blood cells to eliminate solid tumors. … Read More ›

Melanoma is responsible for the large majority of skin cancer deaths, according to the American Cancer Society.

A vaccine is showing promise in staving off the return of one of the deadliest forms of cancer. The vaccine provoked an immune response in half of the pancreatic cancer patients treated during a recent clinical trial, and patients showed no recurrence of their cancer during the course of the yearslong study. Dr. Vinod Balachandran, an attending surgeon at Memorial Sloan Kettering Cancer Center and leader of the…

A personalized cancer vaccine made by BioNTech, the German company that produced the Pfizer-BioNTech COVID-19 vaccine, has shown promising results against pancreatic cancer. The vaccine, which teaches patients' immune systems to attack their tumors, provoked an immune response in half of the 16 pati...

A new tool in the fight against cancer may be just around the corner.

New data from a trial of an investigational mRNA vaccine shows that it reduced the risk of recurrence of the serious skin cancer melanoma when combined with immunotherapy, according to drugmakers Moderna and Merck.

'I think what we have learned is that if you ever thought that mRNA was just for infectious diseases, or just for COVID, the evidence now is that's absolutely not the case,' said Moderna CMO Paul Burton.

Moderna Inc (MRNA.O) said on Tuesday its experimental flu vaccine did not meet the criteria for "early success" in a late-stage trial, and its shares fell 3%.

Pharmaceutical company Moderna predicts it will have developed new vaccines for cancer, cardiovascular disease, and autoimmune diseases by 2030. Promising studies on mRNA therapies have already produced positive results in the development of treatments for rare diseases.